These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25039756)

  • 1. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
    Sonawane P; Cho HE; Tagde A; Verlekar D; Yu AL; Reynolds CP; Kang MH
    Br J Pharmacol; 2014 Dec; 171(23):5330-44. PubMed ID: 25039756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice.
    Conley BA; Ramsland TS; Sentz DL; Wu S; Rosen DM; Wollman M; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(3):183-97. PubMed ID: 9923548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
    Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
    Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
    Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
    Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
    Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
    Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
    Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
    Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 4-oxo-13-cis-retinoic acid as the major metabolite of 13-cis-retinoic acid in human blood.
    Vane FM; Buggé CJ
    Drug Metab Dispos; 1981; 9(6):515-20. PubMed ID: 6120808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 13-cis-retinoic acid and its major metabolite, 4-oxo-13-cis-retinoic acid, in human blood by reversed-phase high-performance liquid chromatography.
    Vane FM; Stoltenborg JK; Buggé CJ
    J Chromatogr; 1982 Feb; 227(2):471-84. PubMed ID: 6460777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid.
    Zage PE; Zeng L; Palla S; Fang W; Nilsson MB; Heymach JV; Zweidler-McKay PA
    Cancer; 2010 May; 116(10):2465-75. PubMed ID: 20225331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
    Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
    Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
    Khan AA; Villablanca JG; Reynolds CP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.
    Kato Y; Salumbides BC; Wang XF; Qian DZ; Williams S; Wei Y; Sanni TB; Atadja P; Pili R
    Mol Cancer Ther; 2007 Jan; 6(1):70-81. PubMed ID: 17237267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
    Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
    Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13-cis retinoic acid and isomerisation in paediatric oncology--is changing shape the key to success?
    Armstrong JL; Redfern CP; Veal GJ
    Biochem Pharmacol; 2005 May; 69(9):1299-306. PubMed ID: 15826600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
    Reynolds CP
    Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid.
    Halakos EG; Connell AJ; Glazewski L; Wei S; Mason RW
    J Proteomics; 2019 Oct; 209():103491. PubMed ID: 31472280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of 9-cis-retinoic acid in healthy men.
    Weber C; Dumont E
    J Clin Pharmacol; 1997 Jul; 37(7):566-74. PubMed ID: 9243349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
    Han G; Chang B; Connor MJ; Sidell N
    Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.